{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:22:00Z","timestamp":1785522120045,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biopha.2017.12.084","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T11:53:44Z","timestamp":1519127624000},"page":"142-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Inotodiol suppresses proliferation of breast cancer in rat model of type 2 diabetes mellitus via downregulation of \u03b2-catenin signaling"],"prefix":"10.1016","volume":"99","author":[{"given":"Xia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2017.12.084_bib0005","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4158\/EP14208.RA","article-title":"Insulin-like growth factors, insulin, and growth hormone signaling in breast cancer: implications for targeted therapy","volume":"20","author":"Beckwith","year":"2014","journal-title":"Endocr. Pract."},{"issue":"11","key":"10.1016\/j.biopha.2017.12.084_bib0010","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrc1476","article-title":"Association studies for finding cancer-susceptibility genetic variants","volume":"4","author":"Pharoah","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.biopha.2017.12.084_bib0015","first-page":"6931","article-title":"Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer","volume":"50","author":"Bonneterre","year":"1990","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2017.12.084_bib0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2017.12.084_bib0025","doi-asserted-by":"crossref","first-page":"e84532","DOI":"10.1371\/journal.pone.0084532","article-title":"Association of polymorphisms and haplotypes in the insulin-like growth factor 1 receptor (IGF1R) gene with the risk of breast cancer in korean women","volume":"9","author":"Kang","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biopha.2017.12.084_bib0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2017.12.084_bib0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gut.2004.052167","article-title":"Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study","volume":"54","author":"Davila","year":"2005","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.biopha.2017.12.084_bib0040","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1158\/1055-9965.EPI-06-0188","article-title":"Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay area, California","volume":"15","author":"Wang","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"11","key":"10.1016\/j.biopha.2017.12.084_bib0045","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1592\/phco.30.11.1159","article-title":"Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs","volume":"30","author":"McFarland","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.biopha.2017.12.084_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/dc11-1313","article-title":"Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival","volume":"35","author":"Currie","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.biopha.2017.12.084_bib0055","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/JME-13-0152","article-title":"A new link between diabetes and cancer: enhanced WNT\/beta-catenin signaling by high glucose","volume":"52","author":"Garcia-Jimenez","year":"2014","journal-title":"J. Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2017.12.084_bib0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BJ20081426","article-title":"Glucose induces an autocrine activation of the Wnt\/beta-catenin pathway in macrophage cell lines","volume":"416","author":"Anagnostou","year":"2008","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.biopha.2017.12.084_bib0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.molcel.2012.11.022","article-title":"Glucose-induced beta-catenin acetylation enhances Wnt signaling in cancer","volume":"49","author":"Chocarro-Calvo","year":"2013","journal-title":"Mol. Cell."},{"issue":"23","key":"10.1016\/j.biopha.2017.12.084_bib0070","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1200\/JCO.2011.39.7505","article-title":"Diabetes, metformin, and breast cancer in postmenopausal women","volume":"30","author":"Chlebowski","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2017.12.084_bib0075","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.biopha.2017.12.084_bib0080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1368-5031.2005.00765.x","article-title":"Type 2 diabetes, psoriasis and thiazolidinediones","volume":"60","author":"Krentz","year":"2006","journal-title":"Int. J. Clin. Pract."},{"issue":"7","key":"10.1016\/j.biopha.2017.12.084_bib0085","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/annonc\/mdr534","article-title":"Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer","volume":"23","author":"He","year":"2012","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2017.12.084_bib0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00253-002-1076-7","article-title":"Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides","volume":"60","author":"Wasser","year":"2002","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2017.12.084_bib0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jep.2005.04.003","article-title":"In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus","volume":"101","author":"Park","year":"2005","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2017.12.084_bib0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/1721727X1301100306","article-title":"Inonotus obliquus suppresses proliferation of colorectal cancer cells and tumor growth in mice models by downregulation of \u03b2-catenin\/NF-\u03baB-signaling pathways","volume":"11","author":"Mishra","year":"2013","journal-title":"Eur. J. Inflamm."},{"issue":"2","key":"10.1016\/j.biopha.2017.12.084_bib0105","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jep.2012.07.008","article-title":"Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice","volume":"143","author":"Mishra","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2017.12.084_bib0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jep.2015.07.030","article-title":"Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the beta-catenin pathway in colorectal cancer","volume":"173","author":"Kang","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2017.12.084_bib0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11094-006-0194-4","article-title":"Chemical and medicobiological properties of Chaga (review)","volume":"40","author":"Shashkina","year":"2006","journal-title":"Pharm. Chem. J."},{"issue":"1","key":"10.1016\/j.biopha.2017.12.084_bib0120","first-page":"65","article-title":"Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective","volume":"19","author":"Wasser","year":"1999","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.biopha.2017.12.084_bib0125","doi-asserted-by":"crossref","first-page":"943516","DOI":"10.1155\/2010\/943516","article-title":"Anti-inflammatory effects of Inonotus obliquus in colitis induced by dextran sodium sulfate","volume":"2010","author":"Choi","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2017.12.084_bib0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/jmf.2006.156","article-title":"Ethanol extract of Inonotus obliquus inhibits lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells","volume":"10","author":"Kim","year":"2007","journal-title":"J. Med. Food"},{"issue":"6","key":"10.1016\/j.biopha.2017.12.084_bib0135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bjp.0704156","article-title":"Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes","volume":"133","author":"Mabley","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2017.12.084_bib0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bjc.6606050","article-title":"Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation","volume":"104","author":"Masur","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2017.12.084_bib0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1534735404274167","article-title":"Controlling hyperglycemia as an adjunct to cancer therapy","volume":"4","author":"Krone","year":"2005","journal-title":"Integr. Cancer Ther."},{"issue":"2","key":"10.1016\/j.biopha.2017.12.084_bib0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0092-8674(00)00122-7","article-title":"Linking colorectal cancer to Wnt signaling","volume":"103","author":"Bienz","year":"2000","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2017.12.084_bib0155","first-page":"F127","article-title":"The adenomatous polyposis coli (APC) tumor suppressor","volume":"1332","author":"Polakis","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2017.12.084_bib0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ijc.20152","article-title":"Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate","volume":"110","author":"Lazarova","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2017.12.084_bib0165","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.yexcr.2007.02.008","article-title":"The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors","volume":"313","author":"Bordonaro","year":"2007","journal-title":"Exp. Cell. Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217353581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217353581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:24:58Z","timestamp":1781591098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217353581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":33,"alternative-id":["S0753332217353581"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.084","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inotodiol suppresses proliferation of breast cancer in rat model of type 2 diabetes mellitus via downregulation of \u03b2-catenin signaling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}